Enovis Corporation Share Price
NYSE: ENOV | Small CapEnovis Corporation Stock Performance
Open $25.45 | Prev. Close $26.50 | Circuit Range N/A |
Day Range $24.76 - $26.79 | Year Range $19.14 - $34.25 | Volume 1,46,179 |
Average Traded $25.84 |
Enovis Corporation Share Price Today
As of 10 August 2026, Enovis Corporation's share price is $26.62. The stock opened at $25.45, compared to its previous close of $26.50. During today's trading session, Enovis Corporation's share price traded between $24.76 and $26.79, with an average price of $25.77. Over the past 52 weeks, the stock has recorded a high of $34.25 and a low of $19.14. In terms of performance, Enovis Corporation's share price has risen by 4.47% over the last six months and is down 13.93% on a year-on-year basis.
Enovis Corporation Share Price Chart
Enovis Corporation Stock Fundamentals & Key Indicators
Market Cap $1.52B | PE Ratio (TTM) -1.28 | Dividend Yield N/A |
EPS (TTM) $-20.75 | Revenue (TTM) $2.25B | Return On Equity (TTM) -79.33% |
Profit Margin -52.57% | Debt to Equity 0.40 | Quarterly Earnings Growth YoY -100.00% |
Enovis Corporation Quarterly Profit & Loss
All figures in USD
Enovis Corporation Annual Profit & Loss
All figures in USD
About Enovis Corporation
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Enovis Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $30.18 | $26.62 | -8.68% |
Jul 2026 | $21.11 | $29.15 | +41.03% |
Jun 2026 | $22.18 | $20.67 | -8.94% |
May 2026 | $23.56 | $22.70 | -3.14% |
Apr 2026 | $22.96 | $23.43 | +3.01% |
Mar 2026 | $24.66 | $22.75 | -10.71% |
Feb 2026 | $21.89 | $25.48 | +15.56% |
Jan 2026 | $26.61 | $22.05 | -17.17% |
Dec 2025 | $30.43 | $26.62 | -12.03% |
Nov 2025 | $30.84 | $30.26 | -3.26% |
Oct 2025 | $30.41 | $31.28 | +3.08% |
Sep 2025 | $30.43 | $30.34 | -1.89% |